Ketoconazole-induced	ketoconazole-induced	O	O
neurologic	neurologic	O	O
sequelae	sequelae	O	O
.	.	O	O

A	a	O	O
77-y-old	77-y-old	O	O
patient	patient	O	O
developed	developed	O	O
weakness	weakness	O	O
of	of	O	O
extremities	extremities	O	O
,	,	O	O
legs	legs	O	O
paralysis	paralysis	O	S_disease
,	,	O	O
dysarthria	dysarthria	O	S_disease
and	and	O	O
tremor	tremor	O	S_disease
1	1	O	O
h	h	O	O
after	after	O	O
ingestion	ingestion	O	O
of	of	O	O
200	200	O	O
mg	mg	O	O
ketoconazole	ketoconazole	O	O
for	for	O	O
the	the	O	O
first	first	O	O
time	time	O	O
in	in	O	O
his	his	S_chemicals	O
life	life	O	O
.	.	O	O

All	all	O	O
complaints	complaints	O	O
faded	faded	O	O
away	away	O	O
within	within	O	O
24	24	O	O
h.	h.	O	O
Few	few	O	O
days	days	O	O
later	later	O	O
,	,	O	O
the	the	O	O
patient	patient	O	O
used	used	O	O
another	another	O	O
200	200	O	O
mg	mg	O	O
ketoconazole	ketoconazole	O	O
tablet	tablet	S_chemicals	O
,	,	O	O
and	and	O	O
within	within	O	O
an	an	O	O
hour	hour	O	O
experienced	experienced	O	O
a	a	O	O
similar	similar	O	O
clinical	clinical	O	O
picture	picture	O	O
,	,	O	O
which	which	O	O
resolved	resolved	O	O
again	again	O	O
spontaneously	spontaneously	O	O
within	within	O	O
hours	hours	O	O
.	.	O	O

Laboratory	laboratory	O	O
evaluations	evaluations	O	O
,	,	O	O
including	including	O	O
head	head	O	O
CT	ct	O	O
scan	scan	O	O
,	,	O	O
were	were	O	O
normal	normal	O	O
.	.	O	O

This	this	O	O
case	case	O	O
illustrates	illustrates	O	O
the	the	O	O
need	need	O	O
for	for	O	O
close	close	O	O
vigilance	vigilance	O	O
in	in	O	O
adverse	adverse	O	B_disease
drug	drug	S_chemicals	B_disease
reactions	reactions	O	I_disease
,	,	O	O
particularly	particularly	O	O
in	in	O	O
the	the	O	O
elderly	elderly	O	O
.	.	O	O

